Reduction of MRONJ risk after exodontia by virtue of ozone infiltration: A randomized clinical trial.
MRONJ
exodontia
healing
imaging
osteonecrosis of the jaw
ozone
prevention
tooth extraction
Journal
Oral diseases
ISSN: 1601-0825
Titre abrégé: Oral Dis
Pays: Denmark
ID NLM: 9508565
Informations de publication
Date de publication:
29 May 2024
29 May 2024
Historique:
revised:
03
04
2024
received:
28
12
2023
accepted:
07
05
2024
medline:
29
5
2024
pubmed:
29
5
2024
entrez:
29
5
2024
Statut:
aheadofprint
Résumé
Exodontia is commonly considered as a risk factor for the development of medication-related osteonecrosis of the jaw (MRONJ) in individuals exposed to bone modifying agents. This study was aimed at assessing the efficiency and safety of a gaseous oxygen-ozone mixture as an adjuvant to a standard exodontia to reduce the risk of MRONJ development. A randomized, open-label, phase II, single-center clinical trial involving 117 patients at risk of MRONJ was conducted. The study protocol tested injections of an oxygen-ozone mixture in the post-extraction site. Participants were randomly assigned to two groups: oxygen-ozone therapy, and standard tooth extraction protocol. Post-extraction wound healing was assessed using the Inflammatory Proliferative Remodeling (IPR) Wound Healing Scale. The oxygen-ozone therapy group exhibited a significant improvement in wound healing post-extraction during the inflammatory and proliferative phases, as indicated by the IPR scale scores at 3-5 days (p = 0.006) and 14 days (p < 0.001) respectively. Oxygen-ozone therapy shows promise in improving post-extraction healing in patients at risk of MRONJ. Future studies with larger sample sizes and multicenter collaborations are recommended to confirm the validity of these findings and explore the long-term efficacy of ozone therapy.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Author(s). Oral Diseases published by Wiley Periodicals LLC.
Références
Adeyemo, W. L., & Lagos, N. (2006). Do pathologies associated with impacted lower third molars justify prophylactic removal? A critical review of the literature. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 102(4), 448–452. https://doi.org/10.1016/j.tripleo.2005.08.015
Arita, M., Nagayoshi, M., Fukuizumi, T., Okinaga, T., Masumi, S., Morikawa, M., Kakinoki, Y., & Nishihara, T. (2005). Microbicidal efficacy of ozonated water against Candida albicans adhering to acrylic denture plates. Oral Microbiology and Immunology, 20, 206–210. https://doi.org/10.1111/J.1399‐302X.2005.00213.X
Azher, S., & Patel, A. (2021). Antibiotics in dentoalveolar surgery, a closer look at infection, alveolar osteitis and adverse drug reaction. Journal of Oral and Maxillofacial Surgery, 79, 2203–2214. https://doi.org/10.1016/J.JOMS.2021.04.019
Azienda Ospedaliera Universitario Policlinico “Paolo Giaccone” di Palermo Prevenzione e Ricerca Sull'Osteonecrosi Delle Ossa Mascellari Da Farmaci. https://www.policlinico.pa.it/portal/pdf/news/2023/PROMAFAOUP.pdf
Bedogni, A., Mauceri, R., Fusco, V., Bertoldo, F., Bettini, G., Di Fede, O., Casto, A. L., Marchetti, C., Panzarella, V., Saia, G., Vescovi, P., & Campisi, G. (2023). Open Peer Review on Qeios Italian position paper (SIPMO‐SICMF) on medication‐related osteonecrosis of the jaw (MRONJ). Qeios. https://doi.org/10.32388/PBUJ6Z
Bedogni, A., Mauceri, R., Fusco, V., Bertoldo, F., Bettini, G., Di Fede, O., Lo Casto, A., Marchetti, C., Panzarella, V., Saia, G., Vescovi, P., & Campisi, G. (2024). Italian position paper (SIPMO‐SICMF) on medication‐related osteonecrosis of the jaw (MRONJ). Oral Diseases, 1–31. https://doi.org/10.1111/ODI.14887
Bermúdez‐Bejarano, E. B., Serrera‐Figallo, M. á., Gutiérrez‐Corrales, A., Romero‐Ruiz, M. M., Castillo‐de‐Oyagüe, R., Gutiérrez‐Pérez, J. L., & Torres‐Lagares, D. (2017). Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates. Journal of Clinical and Experimental Dentistry, 9, e141. https://doi.org/10.4317/JCED.53372
Campisi, G., Mauceri, R., Bertoldo, F., Bettini, G., Biasotto, M., Colella, G., Consolo, U., Di Fede, O., Favia, G., Fusco, V., Gabriele, M., Lo Casto, A., Lo Muzio, L., Marcianò, A., Mascitti, M., Meleti, M., Mignogna, M. D., Oteri, G., Panzarella, V., … Bedogni, A. (2020). Medication‐related osteonecrosis of jaws (MRONJ) prevention and diagnosis: Italian consensus update 2020. International Journal of Environmental Research and Public Health, 17, 1–15. https://doi.org/10.3390/IJERPH17165998
Capocasale, G., Lonardi, F., Signoriello, A., Panozzo, G., Zotti, F., Nocini, R., & Albanese, M. (2021). Open Peer Review on Qeios Prevention of medication‐related osteonecrosis of the jaw (MR‐ONJ) after dentoalveolar surgery in cancer patients: One year experience. Qeios. https://doi.org/10.32388/TTPEZS
Ceponis, P., Keilman, C., Guerry, C., & Freiberger, J. J. (2017). Hyperbaric oxygen therapy and osteonecrosis. Oral Diseases, 23, 141–151. https://doi.org/10.1111/ODI.12489
Chaudhry, K., Rustagi, N., Bali, R., Khatana, S., Kumar, S., Kaur, A., & Kumar, P. (2021). Efficacy of adjuvant ozone therapy in reducing postsurgical complications following impacted mandibular third‐molar surgery: A systematic review and meta‐analysis. Journal of the American Dental Association (1939), 152, 842–854.e1. https://doi.org/10.1016/J.ADAJ.2021.05.006
Coropciuc, R., Coopman, R., Garip, M., Gielen, E., Politis, C., Van den Wyngaert, T., & Beuselinck, B. (2023). Risk of medication‐related osteonecrosis of the jaw after dental extractions in patients receiving Antiresorptive agents – A retrospective study of 240 patients. Bone, 170, 116722. https://doi.org/10.1016/J.BONE.2023.116722
Di Fede, O., Canepa, F., Panzarella, V., Mauceri, R., Del Gaizo, C., Bedogni, A., Fusco, V., Tozzo, P., Pizzo, G., Campisi, G., & Galvano, A. (2021). The treatment of medication‐related osteonecrosis of the jaw (MRONJ): A systematic review with a pooled analysis of only surgery versus combined protocols. International Journal of Environmental Research and Public Health, 18, 8432. https://doi.org/10.3390/IJERPH18168432
Di Fede, O., Del Gaizo, C., Panzarella, V., La Mantia, G., Tozzo, P., Di Grigoli, A., Lo Casto, A., Mauceri, R., & Campisi, G. (2022). Ozone infiltration for osteonecrosis of the jaw therapy: A case series. Journal of Clinical Medicine, 11(18), 5307. https://doi.org/10.3390/jcm11185307
Donati, G. (2019). Drug‐induced jaw osteonecrosis. Ozone Therapy, 4, 48–54. https://doi.org/10.4081/ozone.2019.8698
Ferlito, S., Puzzo, S., & Liardo, C. (2011). Preventive protocol for tooth extractions in patients treated with Zoledronate: A case series. Journal of Oral and Maxillofacial Surgery, 69, e1–e4. https://doi.org/10.1016/J.JOMS.2010.10.055
Freiberger, J. J., Padilla‐Burgos, R., McGraw, T., Suliman, H. B., Kraft, K. H., Stolp, B. W., Moon, R. E., & Piantadosi, C. A. (2012). What is the role of hyperbaric oxygen in the management of bisphosphonate‐related osteonecrosis of the jaw: A randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics. Journal of Oral and Maxillofacial Surgery, 70, 1573–1583. https://doi.org/10.1016/j.joms.2012.04.001
Goker, F., Donati, G., Grecchi, F., Sparaco, A., Ghezzi, M., Rania, V., Rossi, C. A., & Del Fabbro, M. (2020). Treatment of BRONJ with ozone/oxygen therapy and debridement with piezoelectric surgery. European Review for Medical and Pharmacological Sciences, 24, 9094–9103. https://doi.org/10.26355/EURREV_202009_22855
Hamzani, Y., & Chaushu, G. (2018). Evaluation of early wound healing scales/indexes in oral surgery: A literature review. Clinical Implant Dentistry and Related Research, 20, 1030–1035. https://doi.org/10.1111/cid.12680
Kaibuchi, N., Hoshi, K., Yamazaki, A., Miyamoto‐Sangu, N., Akagi, Y., & Okamoto, T. (2021). The progress of medication‐related osteonecrosis of the jaw with conservative initial treatment: A 12‐year retrospective study of 129 patients. Bone Reports, 14, 101072. https://doi.org/10.1016/J.BONR.2021.101072
Karrabi, M., & Baghani, Z. (2022). Amoxicillin/metronidazole dose impact as an adjunctive therapy for stage II‐III grade C periodontitis (aggressive periodontitis) at 3‐and 6‐month follow‐ups: A systematic review and meta analysis. Journal of Oral & Maxillofacial Research, 13, 1–2. https://doi.org/10.5037/jomr.2022.13102
Khan, A., Morrison, A., Cheung, A., Hashem, W., & Compston, J. (2016). Osteonecrosis of the jaw (ONJ): Diagnosis and management in 2015. Osteoporosis International, 27, 853–859. https://doi.org/10.1007/S00198‐015‐3335‐3/TABLES/2
Khan, A. A., Morrison, A., Hanley, D. A., Felsenberg, D., McCauley, L. K., O'Ryan, F., Reid, I. R., Ruggiero, S. L., Taguchi, A., Tetradis, S., Watts, N. B., Brandi, M. L., Peters, E., Guise, T., Eastell, R., Cheung, A. M., Morin, S. N., Masri, B., Cooper, C., … International Task Force on Osteonecrosis of the Jaw. (2015). Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus. Journal of Bone and Mineral Research, 30, 3–23. https://doi.org/10.1002/JBMR.2405
Khan, K. N., Kitajima, M., Hiraki, K., Fujishita, A., Sekine, I., Ishimaru, T., & Masuzaki, H. (2010). Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Human Reproduction, 25, 642–653. https://doi.org/10.1093/HUMREP/DEP437
Kshitish, D., & Laxman, V. K. (2010). The use of Ozonated water and 0.2% chlorhexidine in the treatment of periodontitis patients: A clinical and microbiologic study. Indian Journal of Dental Research, 21, 341–348. https://doi.org/10.4103/0970‐9290.70796
Kunchur, R., Need, A., Hughes, T., & Goss, A. (2009). Clinical investigation of C‐terminal cross‐linking telopeptide test in prevention and management of bisphosphonate‐associated osteonecrosis of the jaws. Journal of Oral and Maxillofacial Surgery, 67, 1167–1173. https://doi.org/10.1016/j.joms.2009.02.004
Kwon, Y. D., & Kim, D. Y. (2016). Role of Teriparatide in medication‐related osteonecrosis of the jaws (MRONJ). Dentistry Journal (Basel), 4, 41. https://doi.org/10.3390/DJ4040041
Li, M., Wang, J., Yu, Y., Zhou, Y., Shi, Y., Zhang, W., Son, G., Ge, J., Zhao, J., Yang, C., & Wang, S. (2022). Characterization of mesenchymal stem cells derived from bisphosphonate‐related osteonecrosis of the jaw patients' gingiva. Stem Cell Reviews and Reports, 18, 378–394. https://doi.org/10.1007/S12015‐021‐10241‐8
Liu, C., Xiong, Y. T., Zhu, T., Liu, W., Tang, W., & Zeng, W. (2023). Management of tooth extraction in patients taking antiresorptive drugs: An evidence mapping review and meta‐analysis. Journal of Clinical Medicine, 12, 239. https://doi.org/10.3390/JCM12010239/S1
Lodi, G., Sardella, A., Salis, A., Demarosi, F., Tarozzi, M., & Carrassi, A. (2010). Tooth extraction in patients taking intravenous bisphosphonates: A preventive protocol and case series. Journal of Oral and Maxillofacial Surgery, 68, 107–110. https://doi.org/10.1016/J.JOMS.2009.07.068
Marcianò, A., Ingrasciotta, Y., Isgrò, V., L'abbate, L., Foti, S. S., Picone, A., Peditto, M., Guzzo, G. M., Alibrandi, A., & Oteri, G. (2021). Cancer patients at risk for medication‐related osteonecrosis of the jaw. A case and control study analyzing predictors of MRONJ onset. Journal of Clinical Medicine, 10(20), 4762. https://doi.org/10.3390/JCM10204762
Materni, A., Pasquale, C., Longo, E., Frosecchi, M., Benedicenti, S., Bozzo, M., & Amaroli, A. (2023). Prevention of dry socket with ozone oil‐based gel after inferior third molar extraction: A double‐blind split‐mouth randomized placebo‐controlled clinical trial. Gels, 9, 289. https://doi.org/10.3390/GELS9040289/S1
Matsumoto, A., Sasaki, M., Schmelzeisen, R., Oyama, Y., Mori, Y., & Voss, P. J. (2017). Primary wound closure after tooth extraction for prevention of medication‐related osteonecrosis of the jaw in patients under denosumab. Clinical Oral Investigations, 21, 127–134. https://doi.org/10.1007/S00784‐016‐1762‐Y
Mauceri, R., Panzarella, V., Maniscalco, L., Bedogni, A., Licata, M. E., Albanese, A., Toia, F., Cumbo, E. M. G., Mazzola, G., Di Fede, O., & Campisi, G. (2018). Conservative surgical treatment of bisphosphonate‐related osteonecrosis of the jaw with Er,Cr:YSGG laser and platelet‐rich plasma: A longitudinal study. BioMed Research International, 2018, 3982540. https://doi.org/10.1155/2018/3982540
Nifosì, G., Nifosì, L., & Nifosì, A. F. (2021). Mesenchymal stem cells in the treatment of osteonecrosis of the jaw. Journal of the Korean Association of Oral and Maxillofacial Surgeons, 47, 65–75. https://doi.org/10.5125/JKAOMS.2021.47.2.65
Otto, S., Aljohani, S., Fliefel, R., Ecke, S., Ristow, O., Burian, E., Troeltzsch, M., Pautke, C., & Ehrenfeld, M. (2021). Infection as an important factor in medication‐related osteonecrosis of the jaw (MRONJ). Medicina (B Aires), 57, 463. https://doi.org/10.3390/MEDICINA57050463
Paoloni, M., Di Sante, L., Cacchio, A., Apuzzo, D., Marotta, S., Razzano, M., Franzini, M., & Santilli, V. (2009). Intramuscular oxygen‐ozone therapy in the treatment of acute back pain with lumbar disc herniation: A multicenter, randomized, double‐blind, clinical trial of active and simulated lumbar paravertebral injection. Spine (Phila Pa 1976), 34, 1337–1344. https://doi.org/10.1097/BRS.0b013e3181a3c18d
Poxleitner, P., Engelhardt, M., Schmelzeisen, R., & Voss, P. (2017). The prevention of medication‐related osteonecrosis of the jaw. Deutsches Ärzteblatt International, 114, 63–69. https://doi.org/10.3238/ARZTEBL.2017.0063
R Core Team (n.d.). R: The R Project for Statistical Computing. Retrieved May 22, 2024, from https://www.r‐project.org/
RANDOM.ORG ‐ List Randomizer. https://www.random.org/lists/
Ripamonti, C. I., Cislaghi, E., Mariani, L., & Maniezzo, M. (2011). Efficacy and safety of medical ozone (O3) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I–II study. Oral Oncology, 47, 185–190. https://doi.org/10.1016/J.ORALONCOLOGY.2011.01.002
Ristow, O., Rückschloß, T., Moratin, J., Müller, M., Kühle, R., Dominik, H., Pilz, M., Shavlokhova, V., Otto, S., Hoffmann, J., & Freudlsperger, C. (2021). Wound closure and alveoplasty after preventive tooth extractions in patients with antiresorptive intake‐a randomized pilot trial. Oral Diseases, 27, 532–546. https://doi.org/10.1111/ODI.13556
Ruggiero, S. L., Dodson, T. B., Fantasia, J., Goodday, R., Aghaloo, T., Mehrotra, B., & O'Ryan, F. (2014). American association of oral and maxillofacial surgeons position paper on medication‐related osteonecrosis of the jaw – 2014 update. Journal of Oral and Maxillofacial Surgery, 72, 1938–1956. https://doi.org/10.1016/J.JOMS.2014.04.031/ATTACHMENT/EDCF5834‐0341‐4F92‐8838‐1C619EF1F88F/MMC1.PDF
Saia, G., Blandamura, S., Bettini, G., Tronchet, A., Totola, A., Bedogni, G., Ferronato, G., Nocini, P. F., & Bedogni, A. (2010). Occurrence of bisphosphonate‐related osteonecrosis of the jaw after surgical tooth extraction. Journal of Oral and Maxillofacial Surgery, 68, 797–804. https://doi.org/10.1016/J.JOMS.2009.10.026
Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials. Annals of Internal Medicine, 152, 726–732. https://doi.org/10.7326/0003‐4819‐152‐11‐201006010‐00232
Scoletta, M., Arduino, P. G., Pol, R., Arata, V., Silvestri, S., Chiecchio, A., & Mozzati, M. (2011). Initial experience on the outcome of teeth extractions in intravenous bisphosphonate‐treated patients: A cautionary report. Journal of Oral and Maxillofacial Surgery, 69, 456–462. https://doi.org/10.1016/J.JOMS.2010.07.026
Sen, S., & Sen, S. (2020). Ozone therapy a new vista in dentistry: Integrated review. Medical Gas Research, 10, 189. https://doi.org/10.4103/2045‐9912.304226
Sim, I. W., Borromeo, G. L., Tsao, C., Hardiman, R., Hofman, M. S., Hjelle, C. P., Siddique, M., Cook, G. J. R., Seymour, J. F., & Ebeling, P. R. (2020). Teriparatide promotes bone healing in medication‐related osteonecrosis of the jaw: A placebo‐controlled, randomized trial. Journal of Clinical Oncology, 38, 2971–2980. https://doi.org/10.1200/JCO.19.02192
Sivalingam, V. P., Panneerselvam, E., Raja, K. V. B., & Gopi, G. (2017). Does topical ozone therapy improve patient comfort after surgical removal of impacted mandibular third molar? A randomized controlled trial. Journal of Oral and Maxillofacial Surgery, 75(51), e1–51.e9. https://doi.org/10.1016/j.joms.2016.09.014
Soutome, S., Otsuru, M., Hayashida, S., Murata, M., Yanamoto, S., Sawada, S., Kojima, Y., Funahara, M., Iwai, H., Umeda, M., & Saito, T. (2021). Relationship between tooth extraction and development of medication‐related osteonecrosis of the jaw in cancer patients. Scientific Reports, 11, 17226. https://doi.org/10.1038/S41598‐021‐96480‐8
Tubiana‐Hulin, M., Spielmann, M., Roux, C., Campone, M., Zelek, L., Gligorov, J., Samson, J., Lesclous, P., Laredo, J. D., & Namer, M. (2009). Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis. Critical Reviews in Oncology/Hematology, 71, 12–21. https://doi.org/10.1016/J.CRITREVONC.2008.10.009
Uschner, D., Schindler, D., Hilgers, R. D., & Heussen, N. (2018). RandomizeR: An R package for the assessment and implementation of randomization in clinical trials. Journal of Statistical Software, 85, 1–22. https://doi.org/10.18637/JSS.V085.I08
Varoni, E. M., Lombardi, N., Villa, G., Pispero, A., Sardella, A., & Lodi, G. (2021). Conservative management of medication‐related osteonecrosis of the jaws (MRONJ): A retrospective cohort study. Antibiotics (Basel), 10(2), 195. https://doi.org/10.3390/antibiotics10020195
Watanabe, T., Asai, K., Fukuhara, S., Uozumi, R., & Bessho, K. (2021). Effectiveness of surgery and hyperbaric oxygen for Antiresorptive agent‐related osteonecrosis of the jaw: A subgroup analysis by disease stage. PLoS One, 16, e0244859. https://doi.org/10.1371/JOURNAL.PONE.0244859
Yahya, B. H., Chaushu, G., & Hamzani, Y. (2021). Evaluation of wound healing following surgical extractions using the IPR scale. International Dental Journal, 71, 133–139. https://doi.org/10.1111/IDJ.12622
Yoneda, T., Hagino, H., Sugimoto, T., Ohta, H., Takahashi, S., Soen, S., Taguchi, A., Nagata, T., Urade, M., Shibahara, T., & Toyosawa, S. (2017). Antiresorptive agent‐related osteonecrosis of the jaw: Position paper 2017 of the Japanese allied committee on osteonecrosis of the jaw. Journal of Bone and Mineral Metabolism, 35, 6–19. https://doi.org/10.1007/S00774‐016‐0810‐7
Zhang, Y., Ma, Y., Jiang, J., Ding, T., & Wang, J. (2013). Treatment of the lumbar disc herniation with intradiscal and intraforaminal injection of oxygen‐ozone. Journal of Back and Musculoskeletal Rehabilitation, 26, 317–322. https://doi.org/10.3233/BMR‐130386
Zhuang, Z. G., Lu, L. J., Peng, B. G., Ma, K., Cai, Z. Y., Fu, Z. J., Liu, G. Z., Liu, J. F., Liu, W. T., Li, X. H., Song, T., Wu, D. S., Yao, J., Yao, P., Yu, J. S., & Liu, Y. Q. (2021). Expert consensus of Chinese Association for the Study of pain on the application of ozone therapy in pain medicine. World Journal of Clinical Cases, 9, 2037–2046. https://doi.org/10.12998/WJCC.V9.I9.2037